Evidence map›Paper›PMID 41613768›Full record

ArticleFrontiers in veterinary science2025

Canine parvovirus type 2 (CPV-2) and bacterial coinfections in dogs: phenotypic and genotypic resistance profiles in northern Kazakhstan.

Yuliya Aleshina, Aigul Zhabykpayeva, Zulkyya Abilova, Yertay Yerzhanov, Andrey Nechaev, Daniyar Madiyev, Zhanaidar Bermukhametov, Raushan Rychshanova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuliya AleshinaThe Laboratory of Clinical Diagnostic, Microbiological Research and Safety of Materials of Biological Origin, Research Institute of Applied Biotechnology, Kostanay Regional University named after Akhmet Baitursynuly, Kostanay, Kazakhstan.
Aigul ZhabykpayevaDepartment of Veterinary Medicine, Kostanay Regional University named after Akhmet Baitursynuly, Kostanay, Kazakhstan.
Zulkyya AbilovaDepartment of Veterinary Medicine, Kostanay Regional University named after Akhmet Baitursynuly, Kostanay, Kazakhstan.
Yertay YerzhanovDepartment of Veterinary Medicine, Kostanay Regional University named after Akhmet Baitursynuly, Kostanay, Kazakhstan.
Andrey NechaevDepartment of General, Private and Operative Surgery, Saint Petersburg State University of Veterinary Medicine, St. Petersburg, Russia.
Daniyar MadiyevDepartment of Veterinary Medicine, Kostanay Regional University named after Akhmet Baitursynuly, Kostanay, Kazakhstan.
Zhanaidar BermukhametovThe Laboratory of Clinical Diagnostic, Microbiological Research and Safety of Materials of Biological Origin, Research Institute of Applied Biotechnology, Kostanay Regional University named after Akhmet Baitursynuly, Kostanay, Kazakhstan.
Raushan RychshanovaThe Laboratory of Clinical Diagnostic, Microbiological Research and Safety of Materials of Biological Origin, Research Institute of Applied Biotechnology, Kostanay Regional University named after Akhmet Baitursynuly, Kostanay, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Canine parvovirus type 2 (CPV-2) poses a serious viral threat to dogs. Despite the potential contribution of companion animals to antimicrobial resistance, data on CPV and associated bacterial coinfections remain limited. This study aimed to characterize the CPV-2 epizootic situation in Kostanay (Kazakhstan), assess bacterial coinfections and AMR profiles, including molecular markers, and evaluate their relevance to One Health. Methods: Epizootiological monitoring revealed a CPV-2 positivity rate of 19.4% ( Results: A total of 131 isolates were obtained (CPV-2 Conclusion: CPV-2 infection is associated with a significant bacterial burden and pronounced AMR, supporting the need for improved surveillance and empirical therapy optimization. These results fill a geographical data gap in Central Asia and align with AMR trends reported in Europe and Asia, underscoring the cross-border circulation of CPV-2 and resistant bacteria and the need for a One Health approach.

Indexed as

antimicrobial resistanceCentral AsiacoinfectionCPV-2cross-border surveillancedogsone healthresistance genes

Identifiers

PMID41613768
PMCPMC12849767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.